Diabetes Research
To learn more about diabetes and clinical trials being carried out in this area, visit our Diabetes Research page.
The purpose of this study is to investigate the efficacy and safety of retatrutide compared with placebo in participants with Type 2 Diabetes and renal impairment, with inadequate glycemic control on basal insulin alone or a combination of basal insulin with or without metformin and/or sodium-glucose cotransporter-2 (SGLT2) inhibitor.
Be 18 years or older
Have a BMI of ≥ 23.0 kg/m^2
Have Type 2 Diabetes
Have high blood sugar as measured by hemoglobin A1C (HbA1c at least 7%)
Have impaired kidney function, an eGFR 15 to <60 mL/min/1.73 m2
Be taking basal Insulin
Have Type 1 Diabetes
Have had or plan to have a surgical treatment for obesity
Have history of an inflamed pancreas (pancreatitis)
Have used any weight loss drugs within the last 3 months
To learn more about diabetes and clinical trials being carried out in this area, visit our Diabetes Research page.
A clinical trial is a scientific study. It helps us learn if a new medicine or treatment works and how it works. Clinical trials can also be called clinical research studies. Learn more about clinical research studies and what to expect when taking part in a clinical trial.